HNW
MEDP icon

High Note Wealth’s Medpace MEDP Stock Holding History

High Note Wealth’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.36K Hold
12
– – ﹤0.01% 515
2026
Q1 		$5.76K Hold
12
– – ﹤0.01% 493
2025
Q4 		$6.74K Sell
12
-1
-8% -$568 ﹤0.01% 413
2025
Q3 		$6.68K Buy
13
+1
+8% +$437 ﹤0.01% 374
2025
Q2 		$3.77K Buy
12
+1
+9% +$300 ﹤0.01% 554
2025
Q1 		$3.35K Buy
11
+5
+83% +$1.68K ﹤0.01% 565
2024
Q4 		$1.99K Buy
+6
New +$2.04K ﹤0.01% 685

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

High Note Wealth's MEDP Position: Q2 2026 in Review

High Note Wealth held its Medpace (MEDP) position steady in Q2 2026 at 12 shares worth $6.36K. The position accounts for ﹤0.01% of the portfolio, ranked #515.

High Note Wealth first reported a position in MEDP in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.74K in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • High Note Wealth held 12 shares of Medpace worth $6.36K as of Q2 2026.
  • High Note Wealth left its Medpace share count unchanged in Q2 2026.
  • Medpace made up ﹤0.01% of High Note Wealth's portfolio in Q2 2026, its #515 holding.
  • High Note Wealth first reported a position in Medpace in Q4 2024 and has held it in 7 quarters since.
  • High Note Wealth's Medpace position peaked at $6.74K in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on High Note Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.